Evidence map›Paper›PMID 39832034›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2025

Optimized breath analysis: customized analytical methods and enhanced workflow for broader detection of VOCs.

Wisenave Arulvasan, Julia Greenwood, Madeleine L Ball, Hsuan Chou, Simon Coplowe, Owen Birch, Patrick Gordon, Andreea Ratiu, Elizabeth Lam, Matteo Tardelli and 8 more

Abstract read
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Wisenave ArulvasanOwlstone Medical Ltd., Cambridge, UK. wisenave.arulvasan@owlstone.co.uk.ORCID http://orcid.org/0009-0001-1207-5953
Julia GreenwoodOwlstone Medical Ltd., Cambridge, UK.
Madeleine L BallOwlstone Medical Ltd., Cambridge, UK.ORCID http://orcid.org/0000-0002-6150-0485
Hsuan ChouOwlstone Medical Ltd., Cambridge, UK.ORCID http://orcid.org/0000-0002-8028-225X
Simon CoploweOwlstone Medical Ltd., Cambridge, UK.ORCID http://orcid.org/0009-0008-7347-844X
Owen BirchOwlstone Medical Ltd., Cambridge, UK.
Patrick GordonOwlstone Medical Ltd., Cambridge, UK.ORCID http://orcid.org/0000-0002-8430-6220
Andreea RatiuOwlstone Medical Ltd., Cambridge, UK.
Elizabeth LamOwlstone Medical Ltd., Cambridge, UK.ORCID http://orcid.org/0000-0003-2273-1392
Matteo TardelliOwlstone Medical Ltd., Cambridge, UK.
Monika SzkatulskaOwlstone Medical Ltd., Cambridge, UK.
Shane SwannOwlstone Medical Ltd., Cambridge, UK.
Steven LevettOwlstone Medical Ltd., Cambridge, UK.
Ella MeadOwlstone Medical Ltd., Cambridge, UK.
Frederik-Jan van SchootenFaculty of Health, Medicine and Life Sciences, Pharmacology and Toxicology, Maastricht University, Maastricht, Netherlands.ORCID http://orcid.org/0000-0001-8111-8198
Agnieszka SmolinskaFaculty of Health, Medicine and Life Sciences, Pharmacology and Toxicology, Maastricht University, Maastricht, Netherlands.ORCID http://orcid.org/0000-0002-1412-4544
Billy BoyleOwlstone Medical Ltd., Cambridge, UK.
Max AllsworthOwlstone Medical Ltd., Cambridge, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBreath Volatile organic compounds (VOCs) are promising biomarkers for clinical purposes due to their unique properties. Translation of VOC biomarkers into the clinic depends on identification and validation: a challenge requiring collaboration, well-established protocols, and cross-comparison of data. Previously, we developed a breath collection and analysis method, resulting in 148 breath-borne VOCs identified.

objectivesTo develop a complementary analytical method for the detection and identification of additional VOCs from breath. To develop and implement upgrades to the methodology for identifying features determined to be "on-breath" by comparing breath samples against paired background samples applying three metrics: standard deviation, paired t-test, and receiver-operating-characteristic (ROC) curve.

methodsA thermal desorption (TD)-gas chromatography (GC)-mass spectrometry (MS)-based analytical method utilizing a PEG phase GC column was developed for the detection of biologically relevant VOCs. The multi-step VOC identification methodology was upgraded through several developments: candidate VOC grouping schema, ion abundance correlation based spectral library creation approach, hybrid alkane-FAMES retention indexing, relative retention time matching, along with additional quality checks. In combination, these updates enable highly accurate identification of breath-borne VOCs, both on spectral and retention axes.

resultsA total of 621 features were statistically determined as on-breath by at least one metric (standard deviation, paired t-test, or ROC). A total of 38 on-breath VOCs were able to be confidently identified from comparison to chemical standards.

conclusionThe total confirmed on-breath VOCs is now 186. We present an updated methodology for high-confidence VOC identification, and a new set of VOCs commonly found on-breath.

Indexed as

Volatile Organic CompoundsBiomarkersBreath TestsGas Chromatography-Mass SpectrometryHumansROC CurveWorkflowBiomarkersVolatile Organic CompoundsBreathomicsMicrobiomeNon-invasive biomarkersVOC AtlasVolatile metabolitesVolatile organic compounds (VOCs)

Identifiers

PMID39832034
PMCPMC11747010

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.